ArticleMedicine2025
Metabolic traits as mediators between excess salt intake and the risk of nonalcoholic fatty liver disease.
Article in Medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Nonalcoholic fatty liver disease (NAFLD) affects approximately 25% of individuals worldwide and poses a significant burden on global health. In this study, we conducted Mendelian randomization analysis using salt added to food (SAF) as the exposure and investigated 249 metabolic traits as potential mediating factors. We applied multiple methods, including inverse-variance-weighted, weighted median, and Mendelian randomization-Egger, to assess causal relationships and detect pleiotropy. Mediation analysis was conducted to identify potential mediators between SAF and NAFLD. Our analysis revealed that higher SAF is associated with an increased risk of NAFLD (beta = 0.38, P = .0056). We identified 6 metabolites associated with SAF. Additionally, we found 106 metabolites associated with NAFLD. Acetate levels were identified as the primary mediator between SAF and NAFLD, mediating approximately 28.08% of the effect. Our study elucidates potential mechanisms by which excessive salt intake increases the risk of NAFLD, highlighting the role of acetate levels as a key mediator. These findings contribute to our understanding of the relationship between salt intake and NAFLD and may inform strategies for prevention and treatment. However, further research is warranted to validate these findings and explore additional mediators and mechanisms involved.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.